group
injectable group
Trial participants receiving eight-weekly injections of cabotegravir and rilpivirine
Most often with
- workThe Lancet 1
- placeZimbabwe 1
- placeUganda 1
- placeSouth Africa 1
- placelow- and middle-income settings 1
- placeKenya 1
- placehigh-income settings 1
- placeHarare 1
- placeAfrica 1
- personSarah Pett 1
- personMutsa Bwakura-Dangarembizi 1
- personDeborah Ford 1
- organisationWorld Health Organization 1
- organisationUCL Innovative Clinical Trials Unit 1
- objectRilpivirine 1
- objectgeneric versions 1